2d955155 686d 40cd 898e Df7d760247a5 740 1
Lamotrigine Tablet
Product Images NDC 68788-7544
7 FDA label images from Preferred Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 68788-7544). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
2d955155 686d 40cd 898e Df7d760247a5 789 2
This image shows four tablets of Lamotrigine, an oral tablet product by Preferred Pharmaceuticals, Inc. It depicts white tablets with strengths 25 mg (oval-shaped, marked 'U U 111'), 100 mg (triangular, marked 'U U 112'), 150 mg (triangular, marked 'U U 113'), and a light blue tablet of 200 mg strength (triangular, marked 'U U 114').*
2d955155 686d 40cd 898e Df7d760247a5 789 3
Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01
Chemical structure of Lamotrigine, showing its molecular framework with chlorine atoms and amine groups clearly depicted as part of its chemical composition.*
Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02
A Kaplan-Meier failure probability curve over time in weeks, comparing Lamotrigine and Placebo. The y-axis shows failure probability (%) and the x-axis shows time in weeks. The graph includes censored data points marked, illustrating differences in failure rates between Lamotrigine and Placebo groups during the study period.*
Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03
A line graph showing failure probability (%) over time in weeks, comparing two groups labeled 'Lamotrigine' and 'Placebo.' The graph includes censored data markers and shows increasing failure probability for both groups over approximately 75 weeks, with the placebo group exhibiting a higher failure probability than the lamotrigine group throughout the timeline.*
Ad7af627 Ea4b 4a78 A71e Db1255416d1e 04
Lamotrigine Tab. USP, 25mg tablet packaging label from Preferred Pharmaceuticals, Inc. The label includes the generic name Lamotrigine, dosage strength 25 mg, tablet form, and states it is generic for Lamictal. It features storage instructions and cautions against transferring the drug to others. The label is primarily yellow and white with English and Spanish dosing instructions."*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
